26.50
Updated 18/06/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 1,815,710
High 26.65
Low 26.14
Open 26.47
ISIN ES0171996087
Prev close 26.50
# of shares -
Market cap -
Intraday

Grifols S.A.
Market is open (until 16:30) - Delayed 15 min
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  26.50 -5.6% Stock price decreasing 5.3% Stock price increasing 19.0% Stock price increasing 8.5% Stock price increasing 1.3% Stock price increasing
Powered by TradingView

Company profile

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 June 2018 12:00:25
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180619.1 - EUROWEB2 - 2018-06-20 13:00:25 - 2018-06-20 12:00:25 - 1000 - Website: OKAY